369 related articles for article (PubMed ID: 11940661)
1. Kinase suppressor of Ras (KSR) is a scaffold which facilitates mitogen-activated protein kinase activation in vivo.
Nguyen A; Burack WR; Stock JL; Kortum R; Chaika OV; Afkarian M; Muller WJ; Murphy KM; Morrison DK; Lewis RE; McNeish J; Shaw AS
Mol Cell Biol; 2002 May; 22(9):3035-45. PubMed ID: 11940661
[TBL] [Abstract][Full Text] [Related]
2. Kinase suppressor of Ras inhibits the activation of extracellular ligand-regulated (ERK) mitogen-activated protein (MAP) kinase by growth factors, activated Ras, and Ras effectors.
Joneson T; Fulton JA; Volle DJ; Chaika OV; Bar-Sagi D; Lewis RE
J Biol Chem; 1998 Mar; 273(13):7743-8. PubMed ID: 9516483
[TBL] [Abstract][Full Text] [Related]
3. Kinase suppressor of ras is necessary for tumor necrosis factor alpha activation of extracellular signal-regulated kinase/mitogen-activated protein kinase in intestinal epithelial cells.
Yan F; Polk DB
Cancer Res; 2001 Feb; 61(3):963-9. PubMed ID: 11221891
[TBL] [Abstract][Full Text] [Related]
4. Kinase suppressor of Ras determines survival of intestinal epithelial cells exposed to tumor necrosis factor.
Yan F; John SK; Polk DB
Cancer Res; 2001 Dec; 61(24):8668-75. PubMed ID: 11751383
[TBL] [Abstract][Full Text] [Related]
5. The kinase suppressor of Ras (KSR) modulates growth factor and Ras signaling by uncoupling Elk-1 phosphorylation from MAP kinase activation.
Sugimoto T; Stewart S; Han M; Guan KL
EMBO J; 1998 Mar; 17(6):1717-27. PubMed ID: 9501093
[TBL] [Abstract][Full Text] [Related]
6. Regulation of the MAP kinase pathway by mammalian Ksr through direct interaction with MEK and ERK.
Yu W; Fantl WJ; Harrowe G; Williams LT
Curr Biol; 1998 Jan; 8(1):56-64. PubMed ID: 9427629
[TBL] [Abstract][Full Text] [Related]
7. Kinase suppressor of Ras forms a multiprotein signaling complex and modulates MEK localization.
Stewart S; Sundaram M; Zhang Y; Lee J; Han M; Guan KL
Mol Cell Biol; 1999 Aug; 19(8):5523-34. PubMed ID: 10409742
[TBL] [Abstract][Full Text] [Related]
8. Expression of kinase suppressor of Ras1 enhances cisplatin-induced extracellular signal-regulated kinase activation and cisplatin sensitivity.
Kim M; Yan Y; Kortum RL; Stoeger SM; Sgagias MK; Lee K; Lewis RE; Cowan KH
Cancer Res; 2005 May; 65(10):3986-92. PubMed ID: 15899786
[TBL] [Abstract][Full Text] [Related]
9. Small molecule stabilization of the KSR inactive state antagonizes oncogenic Ras signalling.
Dhawan NS; Scopton AP; Dar AC
Nature; 2016 Sep; 537(7618):112-116. PubMed ID: 27556948
[TBL] [Abstract][Full Text] [Related]
10. Murine Ksr interacts with MEK and inhibits Ras-induced transformation.
Denouel-Galy A; Douville EM; Warne PH; Papin C; Laugier D; Calothy G; Downward J; Eychène A
Curr Biol; 1998 Jan; 8(1):46-55. PubMed ID: 9427625
[TBL] [Abstract][Full Text] [Related]
11. KSR is a scaffold required for activation of the ERK/MAPK module.
Roy F; Laberge G; Douziech M; Ferland-McCollough D; Therrien M
Genes Dev; 2002 Feb; 16(4):427-38. PubMed ID: 11850406
[TBL] [Abstract][Full Text] [Related]
12. Radicicol suppresses transformation and restores tropomyosin-2 expression in both ras- and MEK-transformed cells without inhibiting the Raf/MEK/ERK signaling cascade.
Kim PN; Jonasch E; Mosterman BC; Mier JW; Janssen RA
Cell Growth Differ; 2001 Nov; 12(11):543-50. PubMed ID: 11714635
[TBL] [Abstract][Full Text] [Related]
13. Paclitaxel induces prolonged activation of the Ras/MEK/ERK pathway independently of activating the programmed cell death machinery.
Okano J ; Rustgi AK
J Biol Chem; 2001 Jun; 276(22):19555-64. PubMed ID: 11278851
[TBL] [Abstract][Full Text] [Related]
14. Sequential activation of the MEK-extracellular signal-regulated kinase and MKK3/6-p38 mitogen-activated protein kinase pathways mediates oncogenic ras-induced premature senescence.
Wang W; Chen JX; Liao R; Deng Q; Zhou JJ; Huang S; Sun P
Mol Cell Biol; 2002 May; 22(10):3389-403. PubMed ID: 11971971
[TBL] [Abstract][Full Text] [Related]
15. C. elegans ksr-1 and ksr-2 have both unique and redundant functions and are required for MPK-1 ERK phosphorylation.
Ohmachi M; Rocheleau CE; Church D; Lambie E; Schedl T; Sundaram MV
Curr Biol; 2002 Mar; 12(5):427-33. PubMed ID: 11882296
[TBL] [Abstract][Full Text] [Related]
16. MEK drives BRAF activation through allosteric control of KSR proteins.
Lavoie H; Sahmi M; Maisonneuve P; Marullo SA; Thevakumaran N; Jin T; Kurinov I; Sicheri F; Therrien M
Nature; 2018 Feb; 554(7693):549-553. PubMed ID: 29433126
[TBL] [Abstract][Full Text] [Related]
17. Constitutive activation of the MEK/ERK pathway mediates all effects of oncogenic H-ras expression in primary erythroid progenitors.
Zhang J; Lodish HF
Blood; 2004 Sep; 104(6):1679-87. PubMed ID: 15166036
[TBL] [Abstract][Full Text] [Related]
18. Epidermal growth factor treatment enhances the kinase activity of kinase suppressor of Ras.
Xing HR; Lozano J; Kolesnick R
J Biol Chem; 2000 Jun; 275(23):17276-80. PubMed ID: 10764733
[TBL] [Abstract][Full Text] [Related]
19. The MAPK scaffold kinase suppressor of Ras is involved in ERK activation by stress and proinflammatory cytokines and induction of arthritis.
Fusello AM; Mandik-Nayak L; Shih F; Lewis RE; Allen PM; Shaw AS
J Immunol; 2006 Nov; 177(9):6152-8. PubMed ID: 17056543
[TBL] [Abstract][Full Text] [Related]
20. Differential contribution of the ERK and JNK mitogen-activated protein kinase cascades to Ras transformation of HT1080 fibrosarcoma and DLD-1 colon carcinoma cells.
Plattner R; Gupta S; Khosravi-Far R; Sato KY; Perucho M; Der CJ; Stanbridge EJ
Oncogene; 1999 Mar; 18(10):1807-17. PubMed ID: 10086335
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
